Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 22nd May 2024
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

CVS Group sells Dutch and Irish businesses for €2
CVS Group has seen significant fianncial losses in its subsidiaries.
The corporation has seen significant losses across the subsidiaries.

CVS Group PLC is to sell its non-core operations in the Netherlands and the Republic of Ireland for just €2.

The corporation announced its decision on Tuesday, stating that the businesses were ‘loss-making’.

Operations in both the Netherlands and the Republic of Ireland have resulted in financial loss for CVS Group. In the financial year ending 30 June 2023, the businesses made the corporation a loss of £6.8m before tax.

They were forecast to end the next financial year with a further loss of £6m.

The businesses have now been sold to Global Veterinary Excellences Limited, for the price of just €2 (£1.70).

Global Veterinary Excellences Limited is owned by James Cahill, a veterinary surgeon and former director of the subsidiaries. Dr Cahill previously worked for CVS Group for six years, and has over 30 years’ experience in the industry.

This decision was made by CVS Group’s chief executive officer, Richard Fairman, in response to the negative contribution the business were making to cash flow. The CEO felt that significant management focus would have been needed to address their failing operational performance.

The sale comes at a challenging time for the large corporation which, in April, was hit by a cyber attack.

The group, which owns 450 practices in the UK, found that unauthorised external access had been made to some of its IT systems. It was forced to take its IT systems temporarily offline, and reported the incident to the Information Commissioner’s Office.

Large corporations like CVS Group also made the headlines in March, when the Competition and Markets Authority (CMA) reported that consolidation from corporate groups could be weakening the veterinary market.

The CMA’s findings suggested that these corporations were limiting consumer choice, by investing in and promoting higher cost treatments to their clients.

Despite these challenges, Mr Fairman said that the low-value sale formed a part of CVS Group’s growth strategy.

Mr Fairman said: "Our Netherlands and Ireland practices no longer fit with our strategy of focusing on growth in the UK and Australian markets.

“We have exciting plans to expand in Australia and this disposal will free up working capital and management capacity to support our continued expansion.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.